Home
Clinical Trials
About Us
Company Overview
Board of Directors
Senior Management
Corporate Directory
Corporate Governance
Lead Candidate
Overview
Clinical Trials
Completed Trials
Microparticle Platform
Publications
Investor Information
Welcome
Investor Fact Sheet
Research
Top 20 Shareholders
Key Dates
Capital Structure
Shareholder Services
Investor FAQs
News & Reports
ASX Announcements
Annual Reports
Media Coverage
Presentations
Patient and Media Reports
Email Alerts
Finance News Network Interviews
Contact Us
Contact Us
Email Alerts
Innate Immunotherapeutics Limited
Home
>
Investor Information
>
Capital Structure
>
Print Page
Capital Structure
Issued fully paid shares
222,848,213
Options
24,160,000
As at 20 February 2017
Welcome
Investor Fact Sheet
Research
Top 20 Shareholders
Key Dates
Capital Structure
Shareholder Services
Investor FAQs